InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Koopman Brian, Chief Financial Officer. Director active across 1 company, notably Utah Medical Products INC. In total, 6 disclosures have been recorded. History available since 27 October 2021. The latest transaction was filed on 4 September 2025 (Don). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Brian Koopman is Directeur Financier and Principal Financial Officer at Utah Medical Products INC, listed on XNAS. He has 6 filings in total, and the 6 sampled filings, from 2021-10-28 to 2025-09-05, show Don transactions with individual amounts of EUR 37185.3564865193, EUR 35522.86390925266, EUR 5807.23099153303, EUR 5169.584043958444, EUR 3284.392448636076 and EUR 2691.535740348649.